191 related articles for article (PubMed ID: 16541471)
1. OX40 (CD134) engagement drives differentiation of CD4+ T cells to effector cells.
Huddleston CA; Weinberg AD; Parker DC
Eur J Immunol; 2006 May; 36(5):1093-103. PubMed ID: 16541471
[TBL] [Abstract][Full Text] [Related]
2. CD25 expression distinguishes functionally distinct alloreactive CD4 CD134 (OX40) T-cell subsets in acute graft-versus-host disease.
Streeter PR; Zhang X; Tittle TV; Schön CN; Weinberg AD; Maziarz RT
Biol Blood Marrow Transplant; 2004 May; 10(5):298-309. PubMed ID: 15111929
[TBL] [Abstract][Full Text] [Related]
3. Growth and differentiation advantages of CD4+ OX40+ T cells from allogeneic hematopoietic stem cell transplantation recipients.
Shindo T; Ishikawa T; Fukunaga A; Hori T; Uchiyama T
Biol Blood Marrow Transplant; 2008 Mar; 14(3):268-81. PubMed ID: 18275893
[TBL] [Abstract][Full Text] [Related]
4. The generation of T cell memory: a review describing the molecular and cellular events following OX40 (CD134) engagement.
Weinberg AD; Evans DE; Thalhofer C; Shi T; Prell RA
J Leukoc Biol; 2004 Jun; 75(6):962-72. PubMed ID: 14996827
[TBL] [Abstract][Full Text] [Related]
5. Characterization of rat OX40 ligand by monoclonal antibody.
Satake Y; Akiba H; Takeda K; Atsuta M; Yagita H; Okumura K
Biochem Biophys Res Commun; 2000 Apr; 270(3):1041-8. PubMed ID: 10772947
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines.
Harrop JA; Reddy M; Dede K; Brigham-Burke M; Lyn S; Tan KB; Silverman C; Eichman C; DiPrinzio R; Spampanato J; Porter T; Holmes S; Young PR; Truneh A
J Immunol; 1998 Aug; 161(4):1786-94. PubMed ID: 9712045
[TBL] [Abstract][Full Text] [Related]
7. Activated T cells express the OX40 ligand: requirements for induction and costimulatory function.
Mendel I; Shevach EM
Immunology; 2006 Feb; 117(2):196-204. PubMed ID: 16423055
[TBL] [Abstract][Full Text] [Related]
8. Endothelial cell co-stimulation through OX40 augments and prolongs T cell cytokine synthesis by stabilization of cytokine mRNA.
Mestas J; Crampton SP; Hori T; Hughes CC
Int Immunol; 2005 Jun; 17(6):737-47. PubMed ID: 15908450
[TBL] [Abstract][Full Text] [Related]
9. Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responses.
Taraban VY; Rowley TF; O'Brien L; Chan HT; Haswell LE; Green MH; Tutt AL; Glennie MJ; Al-Shamkhani A
Eur J Immunol; 2002 Dec; 32(12):3617-27. PubMed ID: 12516549
[TBL] [Abstract][Full Text] [Related]
10. Anti-OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responses.
Ruby CE; Redmond WL; Haley D; Weinberg AD
Eur J Immunol; 2007 Jan; 37(1):157-66. PubMed ID: 17183611
[TBL] [Abstract][Full Text] [Related]
11. gamma(c) cytokines provide multiple homeostatic signals to naive CD4(+) T cells.
Masse GX; Corcuff E; Decaluwe H; Bommhardt U; Lantz O; Buer J; Di Santo JP
Eur J Immunol; 2007 Sep; 37(9):2606-16. PubMed ID: 17683114
[TBL] [Abstract][Full Text] [Related]
12. OX40-mediated differentiation to effector function requires IL-2 receptor signaling but not CD28, CD40, IL-12Rbeta2, or T-bet.
Williams CA; Murray SE; Weinberg AD; Parker DC
J Immunol; 2007 Jun; 178(12):7694-702. PubMed ID: 17548606
[TBL] [Abstract][Full Text] [Related]
13. Cooperation between CD4 and CD8 T cells for anti-tumor activity is enhanced by OX40 signals.
Song A; Song J; Tang X; Croft M
Eur J Immunol; 2007 May; 37(5):1224-32. PubMed ID: 17429847
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of several chemokines but few cytokines by primed uncommitted precursor CD4 T cells suggests that these cells recruit other immune cells without exerting direct effector functions.
Yang L; Mosmann T
Eur J Immunol; 2004 Jun; 34(6):1617-26. PubMed ID: 15162431
[TBL] [Abstract][Full Text] [Related]
15. A signal through OX40 (CD134) allows anergic, autoreactive T cells to acquire effector cell functions.
Lathrop SK; Huddleston CA; Dullforce PA; Montfort MJ; Weinberg AD; Parker DC
J Immunol; 2004 Jun; 172(11):6735-43. PubMed ID: 15153490
[TBL] [Abstract][Full Text] [Related]
16. OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology.
Ishii N; Takahashi T; Soroosh P; Sugamura K
Adv Immunol; 2010; 105():63-98. PubMed ID: 20510730
[TBL] [Abstract][Full Text] [Related]
17. Availability of antigen-presenting cells can determine the extent of CD4 effector expansion and priming for secretion of Th2 cytokines in vivo.
Bradley LM; Harbertson J; Biederman E; Zhang Y; Bradley SM; Linton PJ
Eur J Immunol; 2002 Aug; 32(8):2338-46. PubMed ID: 12209647
[TBL] [Abstract][Full Text] [Related]
18. OX40 ligation enhances cell cycle turnover of Ag-activated CD4 T cells in vivo.
Weatherill AR; Maxwell JR; Takahashi C; Weinberg AD; Vella AT
Cell Immunol; 2001 Apr; 209(1):63-75. PubMed ID: 11414737
[TBL] [Abstract][Full Text] [Related]
19. High levels of human antigen-specific CD4+ T cells in peripheral blood revealed by stimulated coexpression of CD25 and CD134 (OX40).
Zaunders JJ; Munier ML; Seddiki N; Pett S; Ip S; Bailey M; Xu Y; Brown K; Dyer WB; Kim M; de Rose R; Kent SJ; Jiang L; Breit SN; Emery S; Cunningham AL; Cooper DA; Kelleher AD
J Immunol; 2009 Aug; 183(4):2827-36. PubMed ID: 19635903
[TBL] [Abstract][Full Text] [Related]
20. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI
Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
